News & Updates
- Dunad Therapeutics Announces Appointment of Chief Business OfficerFormer uniQure and Nocion Therapeutics Executive Jonathan Garen joins Dunad Therapeutics Leadership Team CAMBRIDGE, England – Aug. 8, 2023 Dunad … Read more
- Dunad Therapeutics Appoints Michael Bonney as Chair of Board of DirectorsBonney brings over 30 years of life sciences industry leadership experience as company advances its covalent chemistry platform for targeted … Read more
- Interview with Dunad CEO Pearl Huang in Nature Reviews Drug DiscoveryDunad CEO Pearl Huang was recently featured in a Q&A interview with Asher Mullard for Nature Reviews Drug Discovery. Check … Read more
- Dunad Therapeutics Announces Appointment of Chief R&D OfficerFormer Novartis and AstraZeneca industry veteran Ruben Tommasi joins Dunad Therapeutics leadership team CAMBRIDGE, England–(BUSINESS WIRE)–Dunad Therapeutics, a biopharmaceutical company … Read more
- Dunad Therapeutics Appoints Industry Veteran Pearl Huang as Chief Executive OfficerDr. Huang brings more than 30 years of biopharma experience, most recently as Chief Executive Officer and President of Flagship … Read more
- Dunad Therapeutics enters Strategic Collaboration with NovartisDunad Therapeutics enters Strategic Collaboration with Novartis to Develop Next-generation Oral Targeted Protein Degrader Therapies Novartis to leverage Dunad’s proprietary … Read more
- Dunad Therapeutics Emerges To Develop Next-generation Small Molecule TherapeuticsDunad Therapeutics Emerges To Develop Next-generation Small Molecule Therapeutics Based On First Tuneable Targeted Protein Degradation Technology CAMBRIDGE, England, March … Read more